Sonova Holding (OTCMKTS:SONVY) Given Average Rating of “Moderate Buy” by Analysts

Shares of Sonova Holding (OTCMKTS:SONVYGet Free Report) have earned an average rating of “Moderate Buy” from the seven ratings firms that are presently covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, one has given a buy rating and two have issued a strong buy rating on the company.

Several research firms have recently weighed in on SONVY. Morgan Stanley raised Sonova from an “underweight” rating to an “equal weight” rating in a research note on Tuesday, June 23rd. Jefferies Financial Group downgraded shares of Sonova from a “hold” rating to a “moderate sell” rating in a research report on Wednesday, March 18th. Citigroup restated a “sell” rating on shares of Sonova in a report on Wednesday, May 13th. Finally, BNP Paribas Exane raised shares of Sonova from a “strong sell” rating to a “strong-buy” rating in a research report on Tuesday, March 10th.

Read Our Latest Analysis on Sonova

Sonova Stock Performance

SONVY stock opened at $50.13 on Friday. The stock has a 50-day moving average price of $48.70 and a two-hundred day moving average price of $49.84. Sonova has a 12-month low of $42.26 and a 12-month high of $61.09. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.75 and a quick ratio of 1.43.

Sonova Company Profile

(Get Free Report)

Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.

Featured Articles

Analyst Recommendations for Sonova (OTCMKTS:SONVY)

Receive News & Ratings for Sonova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sonova and related companies with MarketBeat.com's FREE daily email newsletter.